Overview

A Study to Compare the Pharmacokinetics of Two Different Tablets of Sotorasib in Healthy Participants

Status:
Recruiting
Trial end date:
2021-11-07
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare the pharmacokinetics (PK) of sotorasib dose A administered orally as 3 tablets (test) to sotorasib dose A administered orally as 8 tablets (reference).
Phase:
Phase 1
Details
Lead Sponsor:
Amgen